News

The News section of Health Law Asia provides key updates from the healthcare landscape across China and the wider Asian region.

We share news on industry developments, institutional initiatives, international collaborations, healthcare reforms, and trends affecting the pharmaceutical, medical device, and cosmetics sectors.

A concise and reliable source to stay informed about the economic, legal, and industrial dynamics shaping Asia’s healthcare markets.

China

Measures for Public Security Organs’ Supervision and Inspection of Cyberspace Security

China

Guidelines for Data Property Rights Registration (Trial)

China, Medical Devices

Medical Security Law of the People’s Republic of China

China, Pharma

Strategic Cooperation Agreement Between Centro Einaudi and Health Law Asia

China, Pharma

Action Plan for Promoting Rational Medication Use among Older Adults (2026– 2030)

China, Pharma

Notice of the State Council on Issuing the National Health Plan for the 15th Five-Year Plan Period

China, Pharma

Procedures for the Review and Approval of Applications for Conditional Marketing Authorization of Pharmaceutical Products

China, Pharma

Announcement on Matters Concerning the Application of the Priority Review and Approval Procedures for Drug Marketing Authorization of Chemical Active Pharmaceutical Ingredients

China, Pharma

Interpretation of Announcement on 2026 Medical Insurance Drug Catalog Preliminary Review Results

China, Pharma

Notice on Ensuring the Proper Implementation of Work Related to the Segmented Manufacturing of Biological Products

China, Pharma

Announcement of the 12th National Centralized Volume-Based Procurement of Pharmaceuticals

China, Pharma

Guiding Principles for the Development of Appropriate Pharmaceutical Packaging Specifications

China, Pharma

Guiding Opinions on the Standardized Development of Modern Pharmaceutical Logistics

China, Pharma

Measures for the Administration of Medical Representatives

China, Pharma

Model Anti-monopoly Case Ruled by the Supreme People’s Court (Huang Ltd. et al.)

China, Pharma

Notice on Issuing the Compliance Guidelines for the Online Retail Sale of Prescription Drugs

China, Pharma

Good Clinical Practice for Drug Trials

China, Pharma

Announcement on Strengthening the Supervision and Administration of Entrusted Drug Manufacturing

China, Pharma

Administrative Public Interest Litigation Case Regarding the Rectification of Disguised Sales of Prohibited Online Medicines in the Form of False Online Consultations

China, Pharma

Regulations on Inspection of Exported Drugs and Management of Export Certificates for Pharmaceutical Manufacturers

Pharm.east

Let’s make the point

Newsletter dedicated to Pharmaceutical Legal and Regulatory news on China and Far East Countries.